Daniel Mark James
SEC CIK 2092593 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATOS | ATOSSA THERAPEUTICS, INC. | CFO | 63.0K | — | — | 1 | 2026-03-26 | 2026-03-26 |
Most active insiders at ATOS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Daniel Mark James | CFO | — | — |
| 2 | Cigler Tessa | Dir | — | — |
| 3 | Finn Jonathan | Dir | — | — |
| 4 | Chen Shu-Chih | Dir | — | — |
| 5 | Galli Stephen J | Dir | — | — |
| 6 | Remmel H. Lawrence | Dir | — | — |
| 7 | Steinhart Richard I | Dir | — | — |
| 8 | QUAY STEVEN C | Pres, CEO, Dir | — | — |
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-30 | 2026-03-26 | ATOS | ATOSSA THERAPEUTICS, INC. | Daniel Mark James | CFO | A - Grant | $0.00 | +63.0K | 63.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations